ArticleEJHaem2022

Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.

Muhamed Baljevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.